This alternative framework, termed The Toxic Food Hypothesis, shifts focus away from calorie counting and body weight toward a broader view of metabolic health, recognizing that chronic disease affects those with excess weight as well as millions of lean individuals who share similar metabolic risk factors
Health Canada has approved six medications specifically for chronic weight management: orlistat (Xenical), liraglutide (Saxenda), naltrexone-bupropion (Contrave), semaglutide (Wegovy), tirzepatide (Zepbound), and setmelanotide (Imcivree, for rare genetic forms of obesity only)
When berberine activates it, cells behave as though they are in a low-energy state, even when they are not
Our team has worked with research-grade peptides across hundreds of experimental protocols
Victoza, Saxenda, Ozempic, Wegovy, Rybelsus its not hard to see that Novo Nordisk has become a giant in this space, pioneering first- and second-in-class GLP-1RA obesity medications